Northrop Grumman Corporation (NYSE:NOC) Receives $693.60 Consensus PT from Brokerages

Shares of Northrop Grumman Corporation (NYSE:NOC) have been given a consensus rating of “Moderate Buy” by the twenty-one brokerages that are covering the stock, MarketBeat.com reports. Nine investment analysts have rated the stock with a hold rating, ten have given a buy rating and two have given a strong buy rating to the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $708.65.

NOC has been the subject of several recent research reports. Wall Street Zen raised Northrop Grumman from a “buy” rating to a “strong-buy” rating in a report on Saturday, March 21st. Royal Bank Of Canada boosted their price target on Northrop Grumman from $715.00 to $750.00 and gave the company an “outperform” rating in a report on Wednesday, January 28th. Citigroup boosted their price target on Northrop Grumman from $781.00 to $807.00 and gave the company a “buy” rating in a report on Thursday, April 2nd. Susquehanna reissued a “positive” rating and set a $752.00 price target on shares of Northrop Grumman in a report on Thursday, January 15th. Finally, Wells Fargo & Company initiated coverage on Northrop Grumman in a report on Wednesday, April 1st. They set an “overweight” rating and a $800.00 price target for the company.

Northrop Grumman Stock Performance

Shares of NOC opened at $696.63 on Tuesday. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.10 and a quick ratio of 1.01. Northrop Grumman has a one year low of $450.13 and a one year high of $774.00. The firm has a market capitalization of $98.87 billion, a P/E ratio of 23.91, a PEG ratio of 5.21 and a beta of 0.04. The business has a fifty day moving average of $710.62 and a 200 day moving average of $633.11.

Northrop Grumman (NYSE:NOC) last released its quarterly earnings results on Tuesday, January 27th. The aerospace company reported $7.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.97 by $0.26. Northrop Grumman had a return on equity of 25.57% and a net margin of 9.97%.The business had revenue of $11.71 billion during the quarter, compared to analyst estimates of $11.61 billion. During the same quarter in the previous year, the company posted $6.39 earnings per share. Northrop Grumman’s revenue for the quarter was up 9.6% on a year-over-year basis. Northrop Grumman has set its FY 2026 guidance at 27.400-27.900 EPS. As a group, sell-side analysts anticipate that Northrop Grumman will post 28.05 EPS for the current year.

Northrop Grumman Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 11th. Shareholders of record on Monday, February 23rd were issued a dividend of $2.31 per share. This represents a $9.24 annualized dividend and a yield of 1.3%. The ex-dividend date of this dividend was Monday, February 23rd. Northrop Grumman’s payout ratio is currently 31.72%.

Insider Buying and Selling

In other news, CAO Michael A. Hardesty sold 147 shares of the company’s stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $732.98, for a total value of $107,748.06. Following the completion of the transaction, the chief accounting officer owned 2,525 shares of the company’s stock, valued at $1,850,774.50. This represents a 5.50% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Kathy J. Warden sold 20,000 shares of the company’s stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $708.82, for a total value of $14,176,400.00. Following the completion of the transaction, the chief executive officer directly owned 171,602 shares of the company’s stock, valued at approximately $121,634,929.64. This trade represents a 10.44% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 22,431 shares of company stock worth $15,924,404. Company insiders own 0.23% of the company’s stock.

Hedge Funds Weigh In On Northrop Grumman

A number of hedge funds have recently made changes to their positions in NOC. Parvin Asset Management LLC bought a new position in shares of Northrop Grumman in the second quarter worth about $25,000. Torren Management LLC bought a new position in shares of Northrop Grumman in the fourth quarter worth about $26,000. Karpus Management Inc. bought a new position in shares of Northrop Grumman in the fourth quarter worth about $26,000. Financial Life Planners bought a new position in shares of Northrop Grumman in the third quarter worth about $27,000. Finally, Physician Wealth Advisors Inc. boosted its stake in shares of Northrop Grumman by 200.0% in the third quarter. Physician Wealth Advisors Inc. now owns 48 shares of the aerospace company’s stock worth $29,000 after acquiring an additional 32 shares during the period. Institutional investors own 83.40% of the company’s stock.

Northrop Grumman Company Profile

Northrop Grumman Corporation (NYSE: NOC) is a leading U.S.-based aerospace and defense company that designs, builds and sustains advanced systems, products and technologies for government and commercial customers. Formed through the combination of Northrop and Grumman businesses in the 1990s, the company’s portfolio spans manned and unmanned aircraft, space systems, missile defense, radar and sensor systems, and integrated command, control, communications, computers, intelligence, surveillance and reconnaissance (C4ISR) solutions.

The company’s work includes airframe and platform manufacturing, space hardware and satellite systems, advanced mission systems and cybersecurity services, as well as logistics, sustainment and modernization programs.